Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Sujata Senapati"'
Autor:
Kathleen A. Ross, April M. Tingle, Sujata Senapati, Kaitlyn G. Holden, Michael J. Wannemuehler, Surya K. Mallapragada, Balaji Narasimhan, Marian L. Kohut
Publikováno v:
Immunity & Ageing, Vol 20, Iss 1, Pp 1-14 (2023)
Abstract Background Age-associated impairments of immune response and inflammaging likely contribute to poor vaccine efficacy. An appropriate balance between activation of immune memory and inflammatory response may be more effective in vaccines for
Externí odkaz:
https://doaj.org/article/f0c209bd78e644a7b9ea9b965e400f32
Autor:
Michael J. Wannemuehler, Luman Liu, Amanda E. Ramer-Tait, Ross J. Darling, Sujata Senapati, John Christiansen, Balaji Narasimhan
Publikováno v:
International Journal of Nanomedicine. 15:6579-6592
Introduction Adjuvants and immunotherapies designed to activate adaptive immunity to eliminate infectious disease and tumors have become an area of interest aimed at providing a safe and effective strategy to prevent or eliminate disease. Existing ap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f8341dd7f9740a190d7cd615a32feb5
https://doi.org/10.2147/ijn.s261041
https://doi.org/10.2147/ijn.s261041
Autor:
Michael J. Wannemeuhler, Ross J. Darling, Surya K. Mallapragada, Kathleen A. Ross, Sujata Senapati, Balaji Narasimhan
Publikováno v:
Science Advances
Self-assembling nanoadjuvant scaffolds cross-link B cell receptors and are a new platform technology for therapeutic antibodies.
Host antibody responses are pivotal for providing protection against infectious agents. We have pioneered a new clas
Host antibody responses are pivotal for providing protection against infectious agents. We have pioneered a new clas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b910d952f4befc72438ec05c79c17db
http://europepmc.org/articles/PMC8336949
http://europepmc.org/articles/PMC8336949
Autor:
Justin R. Adams, Surya K. Mallapragada, Michael J. Wannemuehler, Shannon L. Haughney, Balaji Narasimhan, Sujata Senapati
Publikováno v:
Journal of Biomedical Materials Research Part A. 107:1754-1762
Injectable thermogelling polymers have been recently investigated as novel adjuvants and delivery systems for next generation vaccines. As research into natural and synthetic biocompatible polymers progresses, the safety and biocompatibility of these
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68a69c4f3bcc866c91bb849fe05da531
https://doi.org/10.1002/jbm.a.36691
https://doi.org/10.1002/jbm.a.36691
Autor:
Shristi Ghimire, Sankar Renu, Yi Han, Gourapura J. Renukaradhya, Yashavanth Shaan Lakshmanappa, Sujata Senapati, Ninoshkaly Feliciano-Ruiz, Ramesh K Selvaraj, Santosh Dhakal, Balaji Narasimhan
Publikováno v:
Carbohydrate polymers. 243
Poor induction of mucosal immunity in the intestines by current Salmonella vaccines is a challenge to the poultry industry. We prepared and tested an oral deliverable Salmonella subunit vaccine containing immunogenic outer membrane proteins (OMPs) an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fecd348744896868a361efda46b8359
https://pubmed.ncbi.nlm.nih.gov/32532387
https://pubmed.ncbi.nlm.nih.gov/32532387
Autor:
Suren R Gourapura, Yashavanth Shaan Lakshmanappa, Ashley D. Markazi, Revathi Shanmugasundaram, Sankar Renu, Balaji Narasimhan, Sujata Senapati, Santosh Dhakal, Ramesh K Selvaraj, Gourapura J. Renukaradhya
Publikováno v:
International Journal of Nanomedicine. 13:8195-8215
Purpose Salmonellosis is a severe economic threat in poultry and a public health concern. Currently available vaccines are ineffective, and thus, developing effective oral Salmonella vaccine is warranted. Especially, a potent oral vaccine such as the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c3c1055f1709c4510006787cb89e04b
https://doi.org/10.2147/ijn.s185588
https://doi.org/10.2147/ijn.s185588
Autor:
Surya K. Mallapragada, Michael J. Wannemuehler, Darren Loh, Ian C. Schneider, Sujata Senapati, Ross J. Darling, Balaji Narasimhan
Publikováno v:
ACS Biomater Sci Eng
As the focus has shifted from traditional killed or live, attenuated vaccines toward subunit vaccines, improvements in vaccine safety have been confronted with low immunogenicity of protein antigens. This issue has been addressed by synthesizing and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4ff3b41d6e30b6b642aebbb2ba47a25
https://europepmc.org/articles/PMC8627116/
https://europepmc.org/articles/PMC8627116/
Autor:
Siddhartha Panda, Sujata Senapati
Publikováno v:
Thin Solid Films. 599:42-48
Nanoscale films having thicknesses in the range of 92 nm–137 nm were obtained by spin coating V 2 O 5 sol at different stages of aging. The observed structural and morphological changes with time can be attributed to the reactions occurring in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::079de807084af0ad859c763d05c4a3e9
https://doi.org/10.1016/j.tsf.2015.12.045
https://doi.org/10.1016/j.tsf.2015.12.045
Publikováno v:
F1000Research. 9:975
Background: Manganese oxide has been shown to cause toxicity and is associated with occupational-related disease (e.g., welders). With the goal to improve several biomedical areas, manganese oxide nanoparticles (MnO NP) are being considered for use i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5dcf72c38a678cae81ef8294eb86b6b7
https://doi.org/10.12688/f1000research.25238.1
https://doi.org/10.12688/f1000research.25238.1